Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | - | 4,600 | 8,300 | 6,800 | 77,029 | 97,080 | 77,670 | 77,919 |
| Profit before tax | - | - | - | - | 7,170 | 27,833 | 19,114 | 1,382 |
| Net profit | - | - | - | - | 7,170 | 27,833 | 19,081 | 1,299 |
| Equity | 24,230 | 24,244 | 23,454 | 30,285 | 34,625 | 55,290 | 74,404 | 74,370 |
| Liabilities | 0 | 1,792 | 1,234 | 0 | 0 | 26 | 0 | 259 |
| Non-current assets | 0 | 0 | 0 | 75,439 | 59,274 | 43,108 | 26,943 | 10,777 |
| Current assets | 29,116 | 32,983 | 58,945 | 67,009 | 64,018 | 69,090 | 78,023 | 87,422 |
| Total assets | 29,116 | 32,983 | 58,945 | 142,448 | 123,292 | 112,198 | 104,966 | 98,199 |
|
Financial indicators
|
||||||||
| Revenue change y/y | - | - | +80.4% | -18.1% | +1032.8% | +26.0% | -20.0% | +0.3% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | - | - | - | - | 5.8% | 24.8% | 18.2% | 1.3% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - | - | 20.7% | 50.3% | 25.6% | 1.7% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | - | - | - | 9.3% | 28.7% | 24.6% | 1.7% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | 9.3% | 28.7% | 24.6% | 1.8% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | 0.1 | 0.1 | - | - | 0.0 | - | 0.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | - | - | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Social security debts
The company had no debts to Sodra
VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-07-01 | 2026-05-03 | 0.02 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
LIETUVOS INFEKTOLOGU DRAUGIJA (code 191935552) is an Association engaged in activities of professional membership organisations. In the latest financial year 2025, the company generated revenue of €77.9K and net profit of €1.3K, corresponding to a profit margin of 1.7%. Revenue was broadly stable year on year, increasing by 0.3% from 2024, but remained 19.7% below the 2023 level. Profitability weakened sharply in 2025 after stronger results in the previous two years, with net profit declining from €19.1K in 2024 and €27.8K in 2023 to €1.3K. The balance sheet remained solid, with total assets of €98.2K and equity of €74.4K at year-end 2025. Liabilities were minimal at €259, leaving the equity ratio at 75.7%. Asset structure shifted further toward short-term assets, which increased to €87.4K, while long-term assets fell to €10.8K. Key efficiency ratios for 2025 include ROE of 1.8%, ROA of 1.3%, and asset turnover of 0.79x, reflecting a modest asset base and lower earnings in the latest year.